How to Carry on an Effective Community Program of Exercice-oncology.

Sponsor
Asociación Española contra el Cáncer (Other)
Overall Status
Completed
CT.gov ID
NCT05078216
Collaborator
(none)
405
1
18.4
22.1

Study Details

Study Description

Brief Summary

Exercise-oncology is an emerging area, but exist a lack of information about an effective methodology to establish counseling programs long-lasting and not based on research objectives. This observational study objective was to evaluate the feasibility and effective exercise-oncology community intervention in a real patients sample.

Condition or Disease Intervention/Treatment Phase
  • Other: Physical exercise intervention

Detailed Description

The application of exercise-oncology in a real stage is a growing field, having a crucial role throughout the illness. In this sense, exercise has been proved as an effective intervention to prevent reductions in fitness and functional capacity, muscle mass and strength loss; and risings of fat mass, fatigue, anxiety and quality of sleep [1, 2]. Moreover, there has been increasing evidence proving the positive effects of exercise training on some prognostic biomarkers related to cancer such as reductions in sex hormone levels, [3, 4] insulin levels, [5] inflammation levels [6-9] and rising the immune function [10]. The balance of these biomarkers has been directly linked to an improvement in survival in active patients of breast, colon and prostate cancer.

Despite all these benefits, patients and clinical specialists present a reduced adherence to clinical or community exercise-oncology programs, specially when patients are under oncology treatments. In order to provide support, the multidisciplinary roundtable organised by the American College of Sport Medicine (ACSM) published their professional guidelines in 2010 and reviewed in 2018, describing not only the exercise benefits but also the exercise interventions effectiveness [11, 12]. In addition, other institutions, such as the American Cancer Society (ACSM) or the Canadian Society for Exercise Physiology (CSEP), have highlighted the same idea, publishing general recommendations for cancer patients and cancer survivors to support clinicians and promote exercise adherence [13, 14].

However, in Spain, there is still a tremendous lack of these kind of programs. This is really surprising, even more if one considers the statement of the Sociedad Española de Oncología Médica (SEOM) which enlightened the necessity to develop effective community exercise-oncology interventions to support oncologists and patients by ensuring the performance of exercise in safeness conditions as well as a long-lasting adherence to physical exercise [15].

For this reason, the main objective of this pilot experience was to propose a feasible model for the implementation of an exercise-oncology program into specific community programs, providing specific support to clinicians. An effective exercise dose-response, to reduce side effects, as well as the safeness and exercise adherence after the program in cancer patients in different stages, were also evaluated.

Study Design

Study Type:
Observational
Actual Enrollment :
405 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
How to Carry on an Effective Community Program of Exercice-oncology. A Pilot Experience
Actual Study Start Date :
Sep 1, 2018
Actual Primary Completion Date :
Mar 13, 2020
Actual Study Completion Date :
Mar 13, 2020

Arms and Interventions

Arm Intervention/Treatment
Cancer patients

The exercise program consisted of a 12-week supervised intervention, with twice per week sessions of 90 minutes, and was developed in a friendly and close environment, which promoted social interaction between participants. Apart from the twice-weekly supervised sessions, as early as the fifth week, one or two individualized home-based sessions were established for each patient in order to achieve his/her specific objectives with the help of any required supporting material such as documents and video references with exercise examples. All sessions had the same structure: 10 min of warm-up at 60-70% maximal heart rate (MHR), followed by 60-70 minutes of specific training and 10 minutes of stretching exercises. At least, 20% of the total session time was based on cardiovascular work over 70% of the maximum heart rate (MHR)

Other: Physical exercise intervention
12-week supervised intervention, 90 minutes sessions twice per week All sessions had the same structure: 10 min of warm-up at 60-70% maximal heart rate (MHR), followed by 60-70 minutes of specific training and 10 minutes of stretching exercises. At least, 20% of the total session time was based on cardiovascular work over 70% of the maximum heart rate (MHR). Fitness work in the first eight sessions was planned following 30 min of time on cardiovascular exercise 55 min on work out in low to moderate intensity. In the next eight sessions, the time spent on cardiovascular work was slightly increased to 35 min, with 50 min focused on work out, combining moderate to high-intensity sessions. The last eight sessions presented the same structure as the first ones but combining moderate to high intensity.

Outcome Measures

Primary Outcome Measures

  1. Feasibility of an exercise-oncology program [12 weeks]

    to propose a feasible model for the implementation of an exercise-oncology program into specific community programs, providing specific support to clinicians.

Secondary Outcome Measures

  1. Effective dose-response, safeness and adherence [12 weeks]

    To evaluate an effective exercise dose-response to reduce side effects, as well as the safeness and exercise adherence after the program

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Being a cancer patient

  • Being over 18 years

  • Having an Eastern Cooperative Oncology Group (ECOG)≤1,

  • Being e able to walk 500 meters without resting

  • Feeling or presenting any physical side effect related to cancer treatments, like weakness, fatigue, change in body composition, and/or physical pain, without significant clinical implications

Exclusion Criteria:
  • Presenting any physical or psychological disability

  • Having an ejection fraction below 50%

  • Having any American Thoracic Society recommendations to not develop a Cardio Pulmonary Exercise Test

  • Present joint limitations with need of rehabilitation exercise, grade 1-2 lymphedema

  • Presenting active bone metastasis.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Spanish Cancer Association Madrid Spain 28040

Sponsors and Collaborators

  • Asociación Española contra el Cáncer

Investigators

  • Study Director: Soraya Casla Barrio, Phd, Asociación Española contra el Cáncer

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
LUCÍA GIL HERRERO, Exercise physiologist, Asociación Española contra el Cáncer
ClinicalTrials.gov Identifier:
NCT05078216
Other Study ID Numbers:
  • CEI PI 23_2021-v4
First Posted:
Oct 14, 2021
Last Update Posted:
Oct 14, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by LUCÍA GIL HERRERO, Exercise physiologist, Asociación Española contra el Cáncer
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 14, 2021